Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB
- 26 November 2009
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 136 (6), 897-903
- https://doi.org/10.1007/s00432-009-0731-0
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivoAnti-Cancer Drugs, 2009
- Human fortilin is a molecular target of dihydroartemisininFEBS Letters, 2008
- Induction of Apoptosis and Inhibition of Cell Migration and Tube-Like Formation by Dihydroartemisinin in Murine Lymphatic Endothelial CellsPharmacology, 2007
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitroZeitschrift für Krebsforschung und Klinische Onkologie, 2005
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cellsInternational Journal of Cancer, 2003
- Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancerInternational Journal of Cancer, 2003
- Caspase‐8 in Apoptosis: The Beginning of “The End”?IUBMB Life, 2000
- Cancer Cell CyclesScience, 1996